Biopreparedness in the Age of Genetically Engineered Pathogens and Open Access Science: An Urgent Need for a Paradigm Shift

ABSTRACT Our systems, thinking, training, legislation, and policies are lagging far behind momentous changes in science, and leaving us vulnerable in biosecurity. Synthetic viruses and genetic engineering of pathogens are a reality, with a rapid acceleration of dual-use science. The public availability of methods for dual-use genetic engineering, coupled with the insider threat, poses an unprecedented risk for biosecurity. Case studies including the 1984 Rajneesh salmonella bioterrorism attack and the controversy over engineered transmissible H5N1 influenza are analyzed. Simple probability analysis shows that the risks of dual-use research are likely to outweigh potential benefits, yet this type of analysis has not been done to date. Many bioterrorism agents may also occur naturally. Distinguishing natural from unnatural epidemics is far more difficult than other types of terrorism. Public health systems do not have mechanisms for routinely considering bioterrorism, and an organizational culture that is reluctant to consider it. A collaborative model for flagging aberrant outbreak patterns and referral from the health to security sectors is proposed. Vulnerabilities in current approaches to biosecurity need to be reviewed and strengthened collaboratively by all stakeholders. New systems, legislation, collaborative operational models, and ways of thinking are required to effectively address the threat to global biosecurity.

[1]  A. Chughtai,et al.  A Systematic Review of the Comparative Epidemiology of Avian and Human Influenza A H5N1 and H7N9 - Lessons and Unanswered Questions. , 2016, Transboundary and emerging diseases.

[2]  Abrar Ahmad Chughtai,et al.  Uncertainty, risk analysis and change for Ebola personal protective equipment guidelines , 2015, International Journal of Nursing Studies.

[3]  J. Kaiser NIH moving ahead with review of risky virology studies , 2015 .

[4]  C. Macintyre,et al.  Re-thinking the ethics of dual-use research of concern on transmissible pathogens , 2015, Environment Systems and Decisions.

[5]  M. Lipsitch,et al.  Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens , 2014, mBio.

[6]  Larry M. Baddour,et al.  Ebola Virus Disease in Guinea , 2014 .

[7]  C. Macintyre,et al.  The discrepant epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) , 2014, Environment Systems and Decisions.

[8]  S. Reardon Safety lapses in US government labs spark debate , 2014, Nature.

[9]  D. Burke,et al.  Circulating avian influenza viruses closely related to the 1918 virus have pandemic potential. , 2014, Cell host & microbe.

[10]  Ruifu Yang,et al.  Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus , 2014, Nature Communications.

[11]  Theo M Bestebroer,et al.  Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets , 2012, Science.

[12]  B. Maher Bias accusation rattles US biosecurity board , 2012 .

[13]  M. Osterholm,et al.  Life Sciences at a Crossroads: Respiratory Transmissible H5N1 , 2012, Science.

[14]  Y. Kawaoka,et al.  Pause on avian flu transmission studies , 2012, Nature.

[15]  I. Kerridge,et al.  Managing the unimaginable , 2009, EMBO reports.

[16]  William B. Genougreh Update on Dr. Thomas Butler , 2006 .

[17]  A. Balows Biotechnology research—in an age of terrorism , 2004 .

[18]  E. Shuster Fifty years later: the significance of the Nuremberg Code. , 1997, The New England journal of medicine.

[19]  R. Tauxe,et al.  A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. , 1997, JAMA.

[20]  A. J. Hall Infectious diseases of humans: R. M. Anderson & R. M. May. Oxford etc.: Oxford University Press, 1991. viii + 757 pp. Price £50. ISBN 0-19-854599-1 , 1992 .

[21]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[22]  J. Buring,et al.  Epidemiology in Medicine , 1987 .

[23]  M. V. Van Kerkhove Brief literature review for the WHO global influenza research agenda--highly pathogenic avian influenza H5N1 risk in humans. , 2013, Influenza and other respiratory viruses.

[24]  Gregory D. Koblentz From biodefence to biosecurity: the Obama administration's strategy for countering biological threats. , 2012, International affairs.

[25]  J. Hopkins Tanne Infectious diseases expert convicted over missing plague bacteria. , 2003, BMJ.

[26]  Ken Alibek,et al.  Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World--Told from the Inside by the Man Who Ran It , 1999 .